N-Nitroso Fedratinib Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Fedratinib is used to treat adults with certain types of myelofibrosis (MF; a cancer of the bone marrow in which the bone marrow is replaced by scar tissue and causes decreased blood cell production). Fedratinib is in a class of medications called kinase inhibitors.N-Nitroso Fedratinib Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Fedratinib Impurity 1 CAS NO:NA Chemically represented as N-(Tert-butyl)-3-((5-methyl-2-(nitroso(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)amino)pyrimidin-4-yl) (nitroso) amino) benzenesulfonamide .Synchemia is the leading manufacturing and exporter of N-Nitroso Fedratinib Impurity 1.We supply N-Nitroso Fedratinib Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014999 |
| CAS No | NA |
| Mol.F. | C15H17N5O4 |
| Mol.Wt. | 331.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141000 |
| CAS No | NA |
| Mol.F. | C23H27F2N7O6S |
| Mol.Wt. | 567.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141001 |
| CAS No | NA |
| Mol.F. | C26H31F2N7O5S |
| Mol.Wt. | 591.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141002 |
| CAS No | NA |
| Mol.F. | C17H26ClN5O5S |
| Mol.Wt. | 447.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141003 |
| CAS No | NA |
| Mol.F. | C23H28FN7O5S |
| Mol.Wt. | 533.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141004 |
| CAS No | NA |
| Mol.F. | C23H27F2N7O5S |
| Mol.Wt. | 551.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141005 |
| CAS No | NA |
| Mol.F. | C21H23F2N7O4S |
| Mol.Wt. | 507.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141006 |
| CAS No | NA |
| Mol.F. | C21H23F2N7O4S |
| Mol.Wt. | 507.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141007 |
| CAS No | NA |
| Mol.F. | C25H29F2N7O6S |
| Mol.Wt. | 593.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141008 |
| CAS No | NA |
| Mol.F. | C14H22ClN5O5S |
| Mol.Wt. | 407.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141009 |
| CAS No | NA |
| Mol.F. | C21H23F2N7O4S |
| Mol.Wt. | 507.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141010 |
| CAS No | NA |
| Mol.F. | C14H22ClN5O6S |
| Mol.Wt. | 423.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141011 |
| CAS No | NA |
| Mol.F. | C17H26ClN5O5S |
| Mol.Wt. | 447.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141012 |
| CAS No | NA |
| Mol.F. | C15H22ClN5O6S |
| Mol.Wt. | 435.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141013 |
| CAS No | NA |
| Mol.F. | C23H27F2N7O5S |
| Mol.Wt. | 551.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141014 |
| CAS No | NA |
| Mol.F. | C21H33N7O9S |
| Mol.Wt. | 559.6 |
| INV STATUS | CUSTOM SYNTHESIS |